Annual Current Assets
$16.84 M
-$36.38 M-68.36%
December 1, 2023
Summary
- As of February 7, 2025, CATX annual total current assets is $16.84 million, with the most recent change of -$36.38 million (-68.36%) on December 1, 2023.
- During the last 3 years, CATX annual current assets has fallen by -$50.47 million (-74.98%).
- CATX annual current assets is now -74.98% below its all-time high of $67.30 million, reached on June 30, 2021.
Performance
CATX Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$270.17 M
-$24.07 M-8.18%
September 1, 2024
Summary
- As of February 7, 2025, CATX quarterly total current assets is $270.17 million, with the most recent change of -$24.07 million (-8.18%) on September 1, 2024.
- Over the past year, CATX quarterly current assets has increased by +$248.48 million (+1145.72%).
- CATX quarterly current assets is now -8.18% below its all-time high of $294.24 million, reached on June 1, 2024.
Performance
CATX Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
CATX Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -68.4% | +1145.7% |
| 3 y3 years | -75.0% | +571.0% |
| 5 y5 years | +130.2% | +571.0% |
CATX Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -75.0% | at low | -8.2% | +1504.6% |
| 5 y | 5-year | -75.0% | +205.7% | -8.2% | +5592.6% |
| alltime | all time | -75.0% | -100.0% | -8.2% | -100.0% |
Perspective Therapeutics Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $270.17 M(-8.2%) |
| Jun 2024 | - | $294.24 M(+56.3%) |
| Mar 2024 | - | $188.20 M(+1017.8%) |
| Dec 2023 | $81.05 M(+1562.3%) | $16.84 M(-22.4%) |
| Sep 2023 | - | $21.69 M(-32.1%) |
| Jun 2023 | - | $31.95 M(-20.6%) |
| Mar 2023 | - | $40.27 M(-30.0%) |
| Dec 2022 | $4.88 M(-4.6%) | - |
| Sep 2022 | - | $57.54 M(-3.0%) |
| Jun 2022 | - | $59.33 M(-5.5%) |
| Jun 2022 | $5.11 M(+64.1%) | - |
| Mar 2022 | - | $62.76 M(-1.3%) |
| Dec 2021 | - | $63.60 M(-2.1%) |
| Sep 2021 | - | $64.96 M(-3.5%) |
| Jun 2021 | $3.11 M(-2.4%) | - |
| Jun 2021 | - | $67.30 M(-1.1%) |
| Mar 2021 | - | $68.07 M(+453.9%) |
| Dec 2020 | - | $12.29 M(+158.9%) |
| Sep 2020 | - | $4.75 M(-13.8%) |
| Jun 2020 | $3.19 M(+51.5%) | $5.51 M(-3.7%) |
| Mar 2020 | - | $5.72 M(+1.6%) |
| Dec 2019 | - | $5.63 M(-17.3%) |
| Sep 2019 | - | $6.81 M(-7.0%) |
| Jun 2019 | $2.11 M(+4.9%) | $7.32 M(-13.2%) |
| Mar 2019 | - | $8.43 M(-14.1%) |
| Dec 2018 | - | $9.82 M(-12.9%) |
| Sep 2018 | - | $11.27 M(+106.9%) |
| Jun 2018 | $2.01 M(+1.6%) | $5.45 M(-13.9%) |
| Mar 2018 | - | $6.33 M(-14.7%) |
| Dec 2017 | - | $7.42 M(-16.3%) |
| Sep 2017 | - | $8.87 M(-13.8%) |
| Jun 2017 | $1.98 M(-55.8%) | $10.29 M(-13.7%) |
| Mar 2017 | - | $11.92 M(-9.5%) |
| Dec 2016 | - | $13.18 M(-11.7%) |
| Sep 2016 | - | $14.93 M(+9.5%) |
| Jun 2016 | $4.47 M(-33.0%) | $13.63 M(+2.9%) |
| Mar 2016 | - | $13.24 M(-7.3%) |
| Dec 2015 | - | $14.28 M(-6.9%) |
| Sep 2015 | - | $15.34 M(-6.0%) |
| Jun 2015 | $6.68 M(-9.0%) | $16.33 M(+37.3%) |
| Mar 2015 | - | $11.89 M(-7.3%) |
| Dec 2014 | - | $12.83 M(-6.6%) |
| Sep 2014 | - | $13.73 M(-28.6%) |
| Jun 2014 | $7.33 M(+180.8%) | $19.21 M(-23.5%) |
| Mar 2014 | - | $25.11 M(+323.8%) |
| Dec 2013 | - | $5.92 M(-14.2%) |
| Sep 2013 | - | $6.90 M(+55.3%) |
| Jun 2013 | $2.61 M(-22.5%) | $4.44 M(-12.7%) |
| Mar 2013 | - | $5.09 M(-11.2%) |
| Dec 2012 | - | $5.74 M(-11.7%) |
| Sep 2012 | - | $6.50 M(+57.1%) |
| Jun 2012 | $3.37 M | $4.14 M(+3.2%) |
| Mar 2012 | - | $4.01 M(-22.3%) |
| Dec 2011 | - | $5.16 M(+44.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2011 | - | $3.56 M(-15.7%) |
| Jun 2011 | $3.67 M(-17.2%) | $4.22 M(-7.6%) |
| Mar 2011 | - | $4.57 M(-4.8%) |
| Dec 2010 | - | $4.80 M(+68.9%) |
| Sep 2010 | - | $2.84 M(-19.2%) |
| Jun 2010 | $4.43 M(-17.8%) | $3.52 M(-15.3%) |
| Mar 2010 | - | $4.15 M(-15.8%) |
| Dec 2009 | - | $4.93 M(-15.3%) |
| Sep 2009 | - | $5.82 M(-8.4%) |
| Jun 2009 | $5.38 M(-24.0%) | $6.36 M(-15.3%) |
| Mar 2009 | - | $7.50 M(-10.9%) |
| Dec 2008 | - | $8.42 M(-10.1%) |
| Sep 2008 | - | $9.36 M(-12.7%) |
| Jun 2008 | $7.08 M(+63.0%) | $10.73 M(-10.1%) |
| Mar 2008 | - | $11.93 M(-17.3%) |
| Dec 2007 | - | $14.43 M(-19.7%) |
| Sep 2007 | - | $17.97 M(-17.3%) |
| Jun 2007 | $4.35 M(+71.8%) | $21.73 M(-10.0%) |
| Mar 2007 | - | $24.13 M(+370.9%) |
| Dec 2006 | - | $5.12 M(-17.7%) |
| Sep 2006 | - | $6.22 M(+99.1%) |
| Jun 2006 | $2.53 M(>+9900.0%) | $3.13 M(-12.0%) |
| Mar 2006 | - | $3.55 M(+139.8%) |
| Dec 2005 | - | $1.48 M(+108.5%) |
| Sep 2005 | - | $710.50 K(>+9900.0%) |
| Jun 2005 | $0.00(-100.0%) | - |
| Mar 2005 | - | $0.00(0.0%) |
| Dec 2004 | - | $0.00(0.0%) |
| Sep 2004 | $900.00(0.0%) | $0.00(0.0%) |
| Jun 2004 | - | $0.00(0.0%) |
| Mar 2004 | - | $0.00(0.0%) |
| Dec 2003 | - | $0.00(0.0%) |
| Sep 2003 | $900.00(0.0%) | $0.00(0.0%) |
| Jun 2003 | - | $0.00(0.0%) |
| Mar 2003 | - | $0.00(0.0%) |
| Dec 2002 | - | $0.00(0.0%) |
| Sep 2002 | $900.00(0.0%) | $0.00(0.0%) |
| Jun 2002 | - | $0.00(0.0%) |
| Mar 2002 | - | $0.00(0.0%) |
| Dec 2001 | - | $0.00(0.0%) |
| Sep 2001 | $900.00(>+9900.0%) | $0.00(-100.0%) |
| Jun 2001 | - | $900.00(0.0%) |
| Mar 2001 | - | $900.00(-10.0%) |
| Dec 2000 | - | $1000.00(0.0%) |
| Sep 2000 | $0.00(0.0%) | $1000.00(0.0%) |
| Jun 2000 | - | $1000.00(0.0%) |
| Mar 2000 | - | $1000.00(0.0%) |
| Dec 1999 | - | $1000.00(0.0%) |
| Sep 1999 | $0.00(-100.0%) | $1000.00 |
| Sep 1998 | $870.80 K(-20.0%) | - |
| Sep 1997 | $1.09 M(-23.5%) | - |
| Sep 1996 | $1.42 M(-15.9%) | - |
| Sep 1995 | $1.69 M(-16.8%) | - |
| Sep 1994 | $2.03 M | - |
FAQ
- What is Perspective Therapeutics annual total current assets?
- What is the all time high annual current assets for Perspective Therapeutics?
- What is Perspective Therapeutics annual current assets year-on-year change?
- What is Perspective Therapeutics quarterly total current assets?
- What is the all time high quarterly current assets for Perspective Therapeutics?
- What is Perspective Therapeutics quarterly current assets year-on-year change?
What is Perspective Therapeutics annual total current assets?
The current annual current assets of CATX is $16.84 M
What is the all time high annual current assets for Perspective Therapeutics?
Perspective Therapeutics all-time high annual total current assets is $67.30 M
What is Perspective Therapeutics annual current assets year-on-year change?
Over the past year, CATX annual total current assets has changed by -$36.38 M (-68.36%)
What is Perspective Therapeutics quarterly total current assets?
The current quarterly current assets of CATX is $270.17 M
What is the all time high quarterly current assets for Perspective Therapeutics?
Perspective Therapeutics all-time high quarterly total current assets is $294.24 M
What is Perspective Therapeutics quarterly current assets year-on-year change?
Over the past year, CATX quarterly total current assets has changed by +$248.48 M (+1145.72%)